bluebird bio, Inc. (NASDAQ:BLUE) Forecasted to Post Q2 2021 Earnings of ($3.02) Per Share

Retrieved on: 2021-05-10 06:33:45

Tags for this article:

Click the tags to see associated articles and topics

bluebird bio, Inc. (NASDAQ:BLUE) Forecasted to Post Q2 2021 Earnings of ($3.02) Per Share. View article details on hiswai:

Excerpt

The biotechnology company reported ($3.07) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($3.02) by ($0.05).

Article found on: www.marketbeat.com